Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Long-Lived Asset, Class [Axis] Computer Equipment [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Renewed Directors and Officers Liability Insurance Agreement [Member] Related and Nonrelated Parties [Axis] Gensignia Life Sciences Inc [Member] Antidilutive Securities [Axis] Share-Based Payment Arrangement, Option [Member] Warrant [Member] Plan Name [Axis] Incentive Plan [Member] Statistical Measurement [Axis] Maximum [Member] Title and Position [Axis] Employees Directors and Non Employees [Member] Minimum [Member] Board of Directors [Member] Award Type [Axis] Modification of Options [Member] Time Based Options [Member] Performance Based Options [Member] Financial Instrument [Axis] Investment, Name [Axis] Tiziana [Member] Related Party [Member] Services Agreement [Member] Gabriele Cerrone [Member] John Brancaccio [Member] Sean Macdonald [Member] Willy Simon [Member] Keeren Shah [Member] Jeff Fensterer [Member] Joe Flannagan [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Entity Listing, Par Value Per Share Statement of Financial Position [Abstract] ASSETS Current Assets Cash Prepaid expenses Total Current Assets Equipment, net Other non-current assets TOTAL ASSETS LIABILITIES AND SHAREHOLDERS’ EQUITY Current Liabilities Accounts payable Related party payable Accrued expenses Note Payable Total Current Liabilities TOTAL LIABILITIES Shareholders’ Equity Preferred stock $.001 par value; 10,000,000 shares authorized; none issued and outstanding Common stock $.001 par value; 150,000,000 shares authorized; 16,072,267 shares issued and outstanding as of June 30, 2026 and 16,072,267 shares issued and outstanding as of December 31, 2025 Additional paid-in capital Accumulated deficit TOTAL SHAREHOLDERS’ EQUITY TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock shares issued Common stock, shares outstanding Income Statement [Abstract] OTHER INCOME OPERATING EXPENSES Research and development expenses General and administrative expenses Total operating expenses LOSS FROM OPERATIONS Income tax benefit (expense) NET LOSS Net loss per share attributable to common stockholders, basic Net loss per share attributable to common stockholders, diluted Weighted average common shares outstanding used in computing net loss per share attributable to common stockholders, basic Weighted average common shares outstanding used in computing net loss per share attributable to common stockholders, diluted Statement [Table] Statement [Line Items] Balance Balance, shares Share-based compensation Net loss Issuance of common stock Balance, shares Balance Balance, shares Statement of Cash Flows [Abstract] Operating Activities Adjustments to reconcile net loss to net cash used in (provided by) operating activities Depreciation Share-based compensation Expenses settled in stock Change in operating assets and liabilities: Prepaid expenses Accounts payable Related party payable Accrued expenses Net cash used in (provided by) operating activities Financing Activities Advances from related party Payments on note payable Net cash used in (provided by) financing activities (Decrease)/Increase in cash Cash, beginning of period Cash, end of period Supplemental disclosure of noncash investing and financing activities Issuance of Note Payable for payment of prepaid expense Cash paid for interest Shares issued pending non-cash transaction Accounting Policies [Abstract] DESCRIPTION OF BUSINESS SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Property, Plant, and Equipment [Abstract] EQUIPMENT Payables and Accruals [Abstract] ACCRUED EXPENSES Debt Disclosure [Abstract] NOTE PAYABLE Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] NON CURRENT ASSETS Earnings Per Share [Abstract] LOSS PER SHARE Share-Based Payment Arrangement [Abstract] SHARE-BASED COMPENSATION Related Party Transactions [Abstract] RELATED PARTY TRANSACTIONS Income Tax Disclosure [Abstract] INCOME TAXES Other Income OTHER INCOME Subsequent Events [Abstract] SUBSEQUENT EVENTS Basis of Presentation Basis of Consolidation Use of Estimates Comprehensive Loss Other Income Risk and Uncertainties Cash Concentrations of Credit Risk Equipment, net Share-based Compensation Segment Information Recent Accounting Standards SCHEDULE OF PROPERTY AND EQUIPMENT SCHEDULE OF ACCRUED EXPENSES SCHEDULE OF LOSS PER SHARE SCHEDULE OF COMPUTATION OF DILUTED NET LOSS PER SHARE Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] SCHEDULE OF STOCK OPTION ACTIVITY SCHEDULE OF STOCK VALUATION ASSUMPTIONS SCHEDULE OF WARRANTS OUTSTANDING Net loss Accumulated deficit Working capital deficit Property, Plant, and Equipment [Table] Property, Plant, and Equipment [Line Items] Cash equivalents Equipment, useful life Reportable segments Computer equipment Less: Accumulated depreciation Equipment, net Depreciation expense Legal expense R&D expense Total accrued expenses Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Insurance agreement Down payment amount Annual percentage rate Frequency of payments Monthly payments Notes payable Defined Benefit Plan [Table] Defined Benefit Plan Disclosure [Line Items] Shares issued Shares price Consideration value Net Loss Net loss per share attributable to common stockholders Weighted-average common shares outstanding, basic Weighted-average common shares outstanding, diluted Net loss per common share, basic Net loss per common share, diluted Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Anti-dilutive shares Number of Options, Outstanding Weighted Average Exercise Price, Outstanding Weighted Average Remaining Contractual Life (in years) Aggregate Intrinsic Value, Outstanding Number of Options, Issued Weighted Average Exercise Price, Issued Number of Options, Exercised Weighted Average Exercise Price, Exercised Number of Options, Expired/Forfeited Weighted Average Exercise Price, Expired/Forfeited Number of Options, Outstanding Weighted Average Exercise Price, Outstanding Aggregate Intrinsic Value, Outstanding Number of Options, Vested and exercisable Weighted Average Exercise Price, Vested and exercisable Weighted Average Remaining Contractual Life (in years), Vested and exercisable Aggregate Intrinsic Value, Vested and exercisable Weighted Average Remaining Contractual Life (in years), Issued Aggregate Intrinsic Value Issued Weighted Average Remaining Contractual Life (in years), Expired/Forfeited Risk free interest rate Expected dividend yield Expected term Expected volatility DisclosureOfCompensationRelatedCostsSharebasedPaymentsTable [Table] Number of Shares, Outstanding Weighted Average Exercise Price, Outstanding Weighted average remaining contractual life (in years), Outstanding Aggregate Intrinsic Value, Outstanding Number of Shares, Issued Weighted Average Exercise Price, Issued Number of Shares, Exercised Weighted Average Exercise Price, Exercised Number of Shares, Expired/Forfeited Weighted Average Exercise Price, Expired/Forfeited Number of Shares, Outstanding Weighted Average Exercise Price, Outstanding Aggregate Intrinsic Value, Outstanding Shares authorized Awards exercisable period Number of available shares to be issued Number of options granted Weighted average grant date fair value of options granted Number of unvested options Number of options vested Number of options exercise price Fair value of the performance based option modification Share-based compensation expense Unrecognized compensation expense Unrecognized compensation expense, recognized period Unrecognized compensation expenses Related Party Transaction [Table] Related Party Transaction [Line Items] Ownership percentage Cost of Revenue Due to affiliate Funding support Proceeds from related party debt Unpaid fees Other income Research and development accrued liabilities current. Renewed Directors and Officers Liability Insurance Agreement [Member] Gensignia Life Sciences Inc [Member] Incentive Plan [Member] Employees Directors and Non Employees [Member] Board of Directors [Member] Modification of Options [Member] Expenses settled in stock. Time Based Options [Member] Working capital deficit Risks And Uncertainties [Policy Text Block] Share based compensattion options granted. Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest issued. Performance Based Options [Member] Share based compensation arrangements by share based payment award options expired or forfeited in period weighted average remaining contractual life Share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average exercise price. Share based compensation arrangement by share based payment award non option equity instruments grants in period weighted average exercise price. Share based compensation arrangement by share based payment award non option equity instruments exercises in period weighted average exercise price. Share based payment award non option equity instruments forfeitures and expirations weighted average exercise price. Share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average remaining contractual terms. Share based compensation arrangement by share based payment award non option equity instruments aggregate intrinsic value outstanding. Tiziana [Member] Services Agreement [Member] Funding support. Gabriele Cerrone [Member] Unpaid fees. John Brancaccio [Member] Sean Macdonald [Member] Willy Simon [Member] Keeren Shah [Member] Jeff Fensterer [Member] Joe Flannagan [Member] Other Income [Policy Text Block] Other Income [Text Block] Assets, Current Assets Liabilities, Current Liabilities Equity, Attributable to Parent Liabilities and Equity Operating Expenses Operating Income (Loss) Income Tax Expense (Benefit) Shares, Outstanding Share-Based Payment Arrangement, Noncash Expense Increase (Decrease) in Prepaid Expense Increase (Decrease) in Accounts Payable Increase (Decrease) in Due to Related Parties Increase (Decrease) in Accrued Liabilities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Repayments of Notes Payable Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation Other Income [Text Block] Other Income [Policy Text Block] Cash and Cash Equivalents, Policy [Policy Text Block] Property, Plant, and Equipment [Policy Text Block] WorkingCapitalDeficit Property, Plant, and Equipment, Accumulated Depreciation, Depletion, and Amortization Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionEquityInstrumentsAggregateIntrinsicValueOutstanding ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice ShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsWeightedAverageExercisePrice